Understanding the mechanisms of DDR has significant therapeutic implications. Targeting DDR pathways can enhance the efficacy of cancer treatments. For example, PARP inhibitors exploit the defects in homologous recombination repair seen in certain cancers, offering a targeted approach to therapy. Additionally, DDR markers can be used in histological analyses to predict treatment response and disease prognosis.
